Pathophysiological Mechanisms of Myocardial Bridging-Related Angina and Ischemia with Implications for Therapeutic Strategies

Read full text
Authors: Srdjan Aleksandric, Barry F. Uretsky, Ana Djordjevic-Dikic, Dejan Orlic, Nebojsa Antonijevic, Milorad Tesic, Stefan Juricic, Marko D. Banovic, Vojislav Giga, Nikola Boskovic, Zlatko Mehmedbegovic, Ivana Jovanović
+5 more Dejan Simeunovic, Sinisa Stojkovic, Vladan Vukcevic, Goran Stankovic, Branko Beleslin
Cited by: 1
References: 182

Abstract

Myocardial bridging (MB) is a congenital coronary anomaly characterized by systolic compression of the intramyocardial arterial segment and delayed early diastolic artery relaxation, resulting in reduced vessel luminal diameter in diastole. Current evidence suggests that MB, particularly in the left anterior descending artery, may cause anginal symptoms and/or myocardial ischemia through several different pathophysiological and cellular mechanisms acting independently or synergistically: (1) delayed early diastolic relaxation of intramyocardial arterial segment; (2) impaired endothelial-dependent vasodilation with vessel smooth muscle cell hyperactivity in the coronary artery with MB, especially within the bridged segment; (3) focal (septal) ischemia due to "septal steal" phenomenon; and (4) development and progression of an atherosclerotic lesion in the coronary artery segment proximal to MB. Patients with isolated-MB may also experience anginal pain and/or myocardial ischemia due to concomitant structural and/or functional abnormalities of the coronary microcirculation. Both MB and coronary microvascular dysfunction refer to a subgroup of patients with angina and/or ischemia with non-obstructive coronary arteries (ANOCA/INOCA). Therefore, it may be challenging to determine whether MB is causing anginal pain and/or ischemia, particularly since both phenomena have also been reported without MB's existence. Therefore, comprehensive coronary physiology testing should be encouraged in patients with this coronary anomaly to identify the underlying cause of anginal pain and/or myocardial ischemia, enabling optimal therapeutic strategies in these patients. This review is focused on different pathophysiological and cellular mechanisms of MB-related angina and/or ischemia and future perspectives in the functional assessment of MB severity, bearing in mind the complexity of coronary physiology in the presence of this anomaly.

Fields of Study & Subjects

Coronary Artery Anomalies Kawasaki Disease and Coronary Complications Pain Management and Treatment

Publication details

Journal / source
Cells
Publisher
MDPI AG
Volume
15
Issue
10
Pages
888–888
Publication date
13 May 2026
Language
EN